Influenza matrix protein Zn2+ finger peptide

Drug Profile

Influenza matrix protein Zn2+ finger peptide

Alternative Names: Peptide 6

Latest Information Update: 03 Jul 2001

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class
  • Mechanism of Action DNA-directed RNA polymerase modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Influenza virus infections

Most Recent Events

  • 03 Jul 2001 No-Development-Reported for Influenza virus infections in USA (Unknown route)
  • 13 Jan 1998 A study has been added to the pharmacodynamics section
  • 08 Dec 1997 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top